Cargando…
Vascular endothelium–targeted Sirt7 gene therapy rejuvenates blood vessels and extends life span in a Hutchinson-Gilford progeria model
Vascular dysfunction is a typical characteristic of aging, but its contributing roles to systemic aging and the therapeutic potential are lacking experimental evidence. Here, we generated a knock-in mouse model with the causative Hutchinson-Gilford progeria syndrome (HGPS) Lmna(G609G) mutation, call...
Autores principales: | Sun, Shimin, Qin, Weifeng, Tang, Xiaolong, Meng, Yuan, Hu, Wenjing, Zhang, Shuju, Qian, Minxian, Liu, Zuojun, Cao, Xinyue, Pang, Qiuxiang, Zhao, Bosheng, Wang, Zimei, Zhou, Zhongjun, Liu, Baohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7030934/ https://www.ncbi.nlm.nih.gov/pubmed/32128409 http://dx.doi.org/10.1126/sciadv.aay5556 |
Ejemplares similares
-
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome
por: Wang, Ming, et al.
Publicado: (2020) -
Hutchinson-Gilford progeria syndrome
por: Bhukya, Amar Singh, et al.
Publicado: (2015) -
Ocular manifestations in the Hutchinson-Gilford progeria syndrome
por: Chandravanshi, Shivcharan L, et al.
Publicado: (2011) -
Hutchinson-Gilford Progeria Versus Mandibuloacral Dysplasia
por: Mehrez, Mennat Allah I, et al.
Publicado: (2014) -
microRNA deregulation in Hutchinson-Gilford Progeria
por: Roll, Patrice
Publicado: (2015)